Representative Bruce Westerman (R-Arkansas) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on April 21st. The trade occurred in the Representative's "FISHER IRA" account.
Representative Bruce Westerman also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of UniCredit OTCMKTS: UNCRY on 4/21/2025.
- Sold $1,001 - $15,000 in shares of CSX NASDAQ: CSX on 4/21/2025.
- Sold $1,001 - $15,000 in shares of Siemens Aktiengesellschaft OTCMKTS: SIEGY on 4/21/2025.
- Sold $1,001 - $15,000 in shares of GSK NYSE: GSK on 4/21/2025.
- Sold $1,001 - $15,000 in shares of Charles Schwab NYSE: SCHW on 4/21/2025.
- Sold $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 4/21/2025.
- Sold $1,001 - $15,000 in shares of Abbott Laboratories NYSE: ABT on 4/21/2025.
- Sold $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 4/21/2025.
- Sold $15,001 - $50,000 in shares of NVIDIA NASDAQ: NVDA on 4/21/2025.
- Sold $1,001 - $15,000 in shares of Chevron NYSE: CVX on 4/21/2025.
UnitedHealth Group Stock Performance
NYSE UNH opened at $311.23 on Wednesday. UnitedHealth Group Incorporated has a fifty-two week low of $309.10 and a fifty-two week high of $630.73. The stock has a market cap of $282.33 billion, a price-to-earnings ratio of 20.08, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The business has a fifty day moving average of $482.53 and a 200-day moving average of $519.28. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the firm earned $6.91 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.70%. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of UNH. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $28,000. Bayforest Capital Ltd raised its stake in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares in the last quarter. Finally, AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have recently commented on UNH shares. JPMorgan Chase & Co. lowered their price objective on UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Erste Group Bank downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Mizuho boosted their price target on UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Four investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $596.86.
Get Our Latest Report on UnitedHealth Group
About Representative Westerman
Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas' 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.
Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas' 4th Congressional District. He declared candidacy for the 2026 election.
Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.
UnitedHealth Group Company Profile
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.